In another study, an ibotenate-induced neonatal brain injury model was established, and RF also reduced the production of ROS, the level of IL-1β, and the number of reactive astrocytes in the injured neonatal brain while enhancing relevant motor abilities, thus demonstrating a protective effect against neonatal brain injury (37). This evidence concerns the gene IL1B and brain injury.